APA aipamena

Ambel, H. Q., Rengifo, C. D., Sacristán, A. G., Sesmero, J. M., Barahona, A. D., Suarez, S. G., . . . Romero, C. B. (2018). 4CPS-034 Effectiveness and safety of monoclonal antibodies against proprotein convertase subtilisin/kexin 9 (pcsk9 inhibitors) for the treatment of hypercholesterolaemia. Eur J Hosp Pharm.

Chicago Style aipamena

Ambel, H Quiros, C Donoso Rengifo, AA García Sacristán, JM Martinez Sesmero, A Dominguez Barahona, S González Suarez, P Moya Gomez, and C Blazquez Romero. "4CPS-034 Effectiveness and Safety of Monoclonal Antibodies against Proprotein Convertase Subtilisin/kexin 9 (pcsk9 Inhibitors) for the Treatment of Hypercholesterolaemia." Eur J Hosp Pharm 2018.

MLA aipamena

Ambel, H Quiros, et al. "4CPS-034 Effectiveness and Safety of Monoclonal Antibodies against Proprotein Convertase Subtilisin/kexin 9 (pcsk9 Inhibitors) for the Treatment of Hypercholesterolaemia." Eur J Hosp Pharm 2018.